Product category:
Microplates/microarrays and readers
News Release from: RTS Life Science | Subject: Assay Platform
Edited by the Laboratorytalk Editorial
Team on 10 April 2002
Assaying with 1536-well plate technology
Two contracts at a major pharmaceutical firm for low-volume high-throughput assay system
RTS Life Science International says it has won two contracts to supply its Assay Platform to GlaxoSmithKline (GSK), Stevenage One is capable of supporting 1536 well assay plates
This article was originally published on Laboratorytalk on 14 Aug 2001 at 8.00am (UK)
Related stories
Robotic assay platform
RTS Thurnall has combined industrial robotics and technology to create the first advanced Assay Platform capable of supporting high throughput screens
Ultra-high throughput screening at AstraZeneca
Investment in an Assay Platform from RTS Thurnall and Activity Base software from IDBS should result in ultra-high throughput screening (UHTS), claims AstraZeneca
Prime drivers at pharmaceutical companies, it says, are throughput and reagent cost.
In addition, it is important that expensive reader technologies are fully utilised in order to maximise investment.
For these reasons, one of the two Assay Platforms has the distinction of being one of the first large scale, 1536-enabled systems in the UK.
Further reading
World's first automated HCS system?
AstraZeneca will soon take delivery of a custom designed assay platform which automates sub cellular analysis system to evaluate the effect on cellular processes by drug compounds
High-throughput automation for the masses
Standardised, lower cost version of automated HTS system will suit early AdmeTox, assay development, and lead optimisation departments which can't justify a bespoke system
RTS Life Science has incorporated a number of low volume liquid-handling systems, centrifuges, and a multi-modality plate imager onto the system in order to facilitate the effective completion of low volume assays in a high throughput manner.
Sprint 3 software, an inherent part of the Assay Platform, allows user configuration of an unlimited number of assay schedules and simplifies the instrumentation changes necessary to satisfy the user's changing requirements.
This means that developing a new assay will now take under an hour, while, thanks to the ActiveDriver, adding a new device will only take a few minutes.
Sprint's dynamic engine is aware of which devices on the system have redundant capacity and schedules plates through the system, instantly taking into account instrumentation availability.
The two Assay Platforms will feature many back-up instruments, even though each choice has been subjected to rigorous robustness and reliability trials.
An important element of Sprint is that if an individual instrument malfunctions, it will automatically re-schedule any part-completed plate so it completes the assay.
Exchanging instruments quickly is further facilitated by the improved i-Plate, whereby the smaller devices such as the reagent dispensers are mounted on a standard footprint plate, with the option of an in-built telescopic slide, allowing them to be substituted easily and redeployed in a number of different positions within the system.
The industrial robot which sits in the centre of the platform, has a 985mm working envelope and features specially designed 384 well plate and 1536 well plate handling grippers.
It boasts a +/-0.02mm repeatability, and its absolute encoders mean robot homing and time spent in periodic re-teaching of positions is eliminated.
The system includes a comprehensive safety interlock scheme and has been designed to secure both a CE Mark and a UL Field Listing. Request a free brochure from RTS Life Science ...
• RTS Life Science: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
